This review details the physiologic roles of two insulin sensitizers, myo-inositol (MI) and D-chiro-inositol (DCI). In the human ovary, MI is a second messenger of follicle-stimulating hormone (FSH) and DCI is an aromatase inhibitor. These activities allow a treatment for polycystic ovary syndrome (PCOS) to be defined based on the combined administration of MI and DCI, where the best MI:DCI ratio is 40:1. Moreover, MI enhances the effect of metformin and clomiphene on the fertility of PCOS women seeking pregnancy. As impaired intestinal transport may lead to unsuccessful inositol treatment, we also discuss new data on the use of alpha-lactalbumin to boost inositol absorption. Overall, the physiological activities of MI and DCI dictate the dosages and timing of inositol supplementation in the treatment of PCOS.

Inositols in Polycystic Ovary Syndrome: An Overview on the Advances / Facchinetti, Fabio; Unfer, Vittorio; Dewailly, Didier; Kamenov, Zdravko A; Diamanti-Kandarakis, Evanthia; Laganà, Antonio Simone; Nestler, John E; Soulage, ; Christophe, O; Bizzarri, M.. - In: TRENDS IN ENDOCRINOLOGY AND METABOLISM. - ISSN 1879-3061. - 31:6(2020), pp. 435-447. [10.1016/j.tem.2020.02.002]

Inositols in Polycystic Ovary Syndrome: An Overview on the Advances

Unfer, Vittorio;Bizzarri M.
Conceptualization
2020

Abstract

This review details the physiologic roles of two insulin sensitizers, myo-inositol (MI) and D-chiro-inositol (DCI). In the human ovary, MI is a second messenger of follicle-stimulating hormone (FSH) and DCI is an aromatase inhibitor. These activities allow a treatment for polycystic ovary syndrome (PCOS) to be defined based on the combined administration of MI and DCI, where the best MI:DCI ratio is 40:1. Moreover, MI enhances the effect of metformin and clomiphene on the fertility of PCOS women seeking pregnancy. As impaired intestinal transport may lead to unsuccessful inositol treatment, we also discuss new data on the use of alpha-lactalbumin to boost inositol absorption. Overall, the physiological activities of MI and DCI dictate the dosages and timing of inositol supplementation in the treatment of PCOS.
2020
alpha-lactalbumin; aromatase; clomiphene citrate; d-chiro-inositol; in vitro fertilization; insulin resistance; metformin; myo-inositol; polycystic ovary syndrome; testosterone
01 Pubblicazione su rivista::01a Articolo in rivista
Inositols in Polycystic Ovary Syndrome: An Overview on the Advances / Facchinetti, Fabio; Unfer, Vittorio; Dewailly, Didier; Kamenov, Zdravko A; Diamanti-Kandarakis, Evanthia; Laganà, Antonio Simone; Nestler, John E; Soulage, ; Christophe, O; Bizzarri, M.. - In: TRENDS IN ENDOCRINOLOGY AND METABOLISM. - ISSN 1879-3061. - 31:6(2020), pp. 435-447. [10.1016/j.tem.2020.02.002]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1682462
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 32
  • Scopus 68
  • ???jsp.display-item.citation.isi??? 58
social impact